Boule Diagnostics AB BOUL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 1.22
- Day Range
- SEK 1.13–1.30
- 52-Week Range
- SEK 0.84–6.26
- Bid/Ask
- SEK 1.21 / SEK 1.30
- Shares Outstanding
- 38.83M
- Market Cap
- SEK 47.38M
- Volume/Avg
- 76,094 / 270,198
Key Statistics
- Price/Earnings (Normalized)
- 27.15
- Price/Sales
- 0.11
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. the company operating through two complementary business segments: Diagnostics and OEM CDS. Through its subsidiaries, the company operates in USA ,Asia, Eastern Europe, Latin America Western Europe and Africa / Middle East. The majority revenue is generated from Asia.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 178
- Website
- https://www.boule.com
Valuation
Metric | BOUL |
|---|---|
Price/Earnings (Normalized) | 27.15 |
Price/Book Value | 0.29 |
Price/Sales | 0.11 |
Price/Cash Flow | — |
Price/Earnings
BOUL
Financial Strength
Metric | BOUL |
|---|---|
Quick Ratio | 0.62 |
Current Ratio | 0.92 |
Interest Coverage | 0.24 |
Quick Ratio
BOUL
Profitability
Metric | BOUL |
|---|---|
Return on Assets (Normalized) | −2.71% |
Return on Equity (Normalized) | −7.49% |
Return on Invested Capital (Normalized) | 0.21% |
Return on Assets
BOUL
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|LV^$z< | LOCK|yYxG^ | $190B | |||
| Medtronic PLC MDT | LOCK|R?LrwY | LOCK|ks&#K | $130B | |||
| Stryker Corp SYK | LOCK|Qr?qNw&V | LOCK|NVz | $124B | |||
| Boston Scientific Corp BSX | LOCK|&K$hmw | LOCK|#hQC! | $62B | |||
| Edwards Lifesciences Corp EW | LOCK|f$Pq$c> | LOCK|$ZBTg | $59B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|pk&&&!T | LOCK|$z | $37B | |||
| Koninklijke Philips NV ADR PHG | LOCK|p$ | LOCK|&w | $30B | |||
| DexCom Inc DXCM | LOCK|hDN$w?! | LOCK|gGW% | $30B | |||
| Steris PLC STE | LOCK|?sZ<g@X | LOCK|V@z?F | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|?hk?^zr | LOCK|t? | $20B |
United States